Loading...
Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC.
Haslett, Kate Blackhall, Fiona H Koh, P Ashcroft, Linda Asselin, Marie-Claude Harris, Catherine Jackson, A Manoharan, Prakash Mullan, Damian Ryder, W David J
Haslett, Kate
Blackhall, Fiona H
Koh, P
Ashcroft, Linda
Asselin, Marie-Claude
Harris, Catherine
Jackson, A
Manoharan, Prakash
Mullan, Damian
Ryder, W David J
Citations
Altmetric:
Abstract
Description
Date
2018
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Phase I trial evaluating MEK inhibitor selumetinib with concomitant thoracic radiotherapy in NSCLC. 2018, 127: S387-S387 Radiother Oncol